Original news and analysis on international IP policy
Mario Ottiglio is stepping down as director of public affairs, communications & global health policy at the International Federation of Pharmaceutical Manufacturers in Geneva. He will be staying in Geneva as the managing director of the new office of the High Lantern Group, a US consulting firm.
The World Intellectual Property Organization Committee on Development and Intellectual Property (CDIP) is meeting this week with an agenda including the presentation of a first review on how well WIPO implemented its Development Agenda Recommendations from 2008 to 2015. Also on the agenda is a discussion on what United Nations Sustainable Development Goals can be applied to WIPO’s work, and what the role of WIPO is in technology transfer.
As the head of the World Health Organization warned of funding shortfalls at this week’s financing dialogue, she also proposed to raise assessed country contributions by 10 percent to help mitigate the situation. However, countries had a different take on the suggestion, which is expected to be further considered in the discussions on the budget for 2018/2019, at the Executive Board meeting in January, and at the annual World Health Assembly next May.
For next week's World Trade Organization intellectual property committee meeting, the major developing economies have submitted a request to discuss the recently released report of the United Nations Secretary General's High-Level Panel on Access to Medicines, according to Knowledge Ecology International (KEI). A key element of the UN report was to make it harder for countries deter or discourage other countries from trying to use patent flexibilities built into the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) - something the major developing economies have been discouraged from doing in the past.
World Health Organization Director General Margaret Chan today warned of serious funding shortfalls for the current biennium endangering the implementation of certain programmes. Areas most in need of financing include non-communicable diseases (such as cancer, diabetes and cardiovascular diseases), food security, and antimicrobial resistance. The high-profile Health Emergencies Programme is also underfunded and Chan proposed to ask countries to raise their assessed contributions at the next World Health Assembly.
With a delay of mere days, CETA, the Comprehensive Economic and Trade Agreement between the European Union and Canada, will be signed Sunday in Brussels by Canadian Prime Minister Justin Trudeau, European Council President Donald Tusk and European Commission President Jean Claude Juncker. This follows two weeks of uncertainty over the deal that includes not only tariff reduction, but also an attempt to harmonise regulation and set up a reformed investor-state dispute settlement (ISDS) mechanism.
Poland’s Ministry of Economic Development has announced it is developing a package of 11 executive ordinances - of which nine are yet to be signed by the minister - to improve the procedures for obtaining trademarks and contacting the Polish Patent Office, reduce the costs of registering and protecting trademarks and industrial designs, and facilitate these procedures for small- and medium-size companies.
A new report by respected economists under the European Commission has found that problems of patent assertion entities in Europe could be better controlled if patent quality stays high in the region. It also found that the majority of patent assertion entities in Europe have focused on vulnerable targets – mainly in the telecommunications sector - and the report provides significant research on such entities operating in the European Union. The findings shine light on the key role of standard essential patents, with suggestions for policymakers and predictions about the impact of the prospective changes to the European patent system.
Innovations in medicine bring the hope of cure for millions of patients who can access them. When a novel effective hepatitis C drug was put on the market at very high prices, concerns erupted about access in both developing and developed countries. A new report by the World Health Organization found that over one million people have received new treatment for hepatitis C in developing countries. The report, which targets high prices as a major barrier to access to treatment, also compiles ways countries have overcome the access barriers.
High drug prices are a global public health crisis. This is mostly the case among lower income countries but also for citizens and residents in the US, where tens of millions are not filling prescriptions due to cost. The international online marketplace is a much-needed lifeline for consumers who cannot afford prescription medication where they live. People deserve the widest possible access to safe and affordable medication, including online access, and the Internet community can help, says Gabriel Levitt.
Raising awareness, creating effective stewardship, national action plans on antimicrobial resistance, building trust and getting onto the agenda of the G20 are critical to fostering access and appropriate use of antibiotics, according to speakers at yesterday’s joint technical symposium on antimicrobial resistance (AMR).
While the issue of antimicrobial resistance has arrived in high-level discussions, and there is a consensus that the problem must be tackled one way or another to avoid slipping back into a pre-antibiotic era, some voices are highlighting the need to remember that other health issues remain unmet, and access to medicines is still an acute problem.